{"id":"https://openalex.org/W7117739596","doi":"https://doi.org/10.1158/2767-9764.30977621","title":"Supplemental Table S1 from Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors","display_name":"Supplemental Table S1 from Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors","publication_year":2025,"publication_date":"2025-12-31","ids":{"openalex":"https://openalex.org/W7117739596","doi":"https://doi.org/10.1158/2767-9764.30977621"},"language":"en","primary_location":{"id":"doi:10.1158/2767-9764.30977621","doi":"https://doi.org/10.1158/2767-9764.30977621","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.30977621","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Table_S1_from_Phase_1b_Study_of_Dazostinag_plus_Pembrolizumab_after_Hypofractionated_Radiotherapy_in_Patients_with_Select_Advanced_Solid_Tumors/30977621/1/files/60717029.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Table_S1_from_Phase_1b_Study_of_Dazostinag_plus_Pembrolizumab_after_Hypofractionated_Radiotherapy_in_Patients_with_Select_Advanced_Solid_Tumors/30977621/1/files/60717029.pdf","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034538179","display_name":"Benjamin Thomas Cooper","orcid":"https://orcid.org/0000-0002-7044-7989","observed_orcids":["https://orcid.org/0000-0002-7044-7989"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin T. Cooper","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7044-7989","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018378822","display_name":"Wade Thomas Iams","orcid":"https://orcid.org/0000-0003-2109-298X","observed_orcids":["https://orcid.org/0000-0003-2109-298X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wade T. Iams","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2109-298X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5121663023","display_name":"David B. Page","orcid":"https://orcid.org/0000-0001-9264-4628","observed_orcids":["https://orcid.org/0000-0001-9264-4628"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David B. Page","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9264-4628","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5121680797","display_name":"Yuan Yuan","orcid":"https://orcid.org/0000-0001-7440-8939","observed_orcids":["https://orcid.org/0000-0001-7440-8939"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuan Yuan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7440-8939","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020607218","display_name":"Naamit Kurshan Gerber","orcid":"https://orcid.org/0000-0002-6061-0498","observed_orcids":["https://orcid.org/0000-0002-6061-0498"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naamit K. Gerber","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6061-0498","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063337705","display_name":"Jason J. Luke","orcid":"https://orcid.org/0000-0002-1182-4908","observed_orcids":["https://orcid.org/0000-0002-1182-4908"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason J. Luke","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1182-4908","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011111764","display_name":"John P. Gibbs","orcid":"https://orcid.org/0000-0001-8892-7318","observed_orcids":["https://orcid.org/0000-0001-8892-7318"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John P. Gibbs","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8892-7318","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059720723","display_name":"Richard C. Gregory","orcid":"https://orcid.org/0000-0002-5041-1882","observed_orcids":["https://orcid.org/0000-0002-5041-1882"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard C. Gregory","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5041-1882","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019034689","display_name":"Kwok\u2010Kin Wong","orcid":"https://orcid.org/0000-0001-6323-235X","observed_orcids":["https://orcid.org/0000-0001-6323-235X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kwok-Kin Wong","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6323-235X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017293928","display_name":"Jiehui Deng","orcid":"https://orcid.org/0000-0001-7986-8643","observed_orcids":["https://orcid.org/0000-0001-7986-8643"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jiehui Deng","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7986-8643","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014226062","display_name":"Samanthi A. Perera","orcid":"https://orcid.org/0000-0003-1915-7086","observed_orcids":["https://orcid.org/0000-0003-1915-7086"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samanthi A. Perera","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1915-7086","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089359056","display_name":"Kai Ding","orcid":"https://orcid.org/0000-0002-3508-465X","observed_orcids":["https://orcid.org/0000-0002-3508-465X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kai Ding","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3508-465X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112726042","display_name":"Emily R. Roberts","orcid":"https://orcid.org/0009-0009-9672-0443","observed_orcids":["https://orcid.org/0009-0009-9672-0443"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emily R. Roberts","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-9672-0443","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010026747","display_name":"Allison Berger","orcid":"https://orcid.org/0000-0003-1217-2005","observed_orcids":["https://orcid.org/0000-0003-1217-2005"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Allison Berger","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1217-2005","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013721197","display_name":"Camilla Laulund Christensen","orcid":"https://orcid.org/0009-0007-3313-2615","observed_orcids":["https://orcid.org/0009-0007-3313-2615"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Camilla L. Christensen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0007-3313-2615","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5121686632","display_name":"Erica Xin Tong","orcid":"https://orcid.org/0009-0003-3229-527X","observed_orcids":["https://orcid.org/0009-0003-3229-527X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erica Xin Tong","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-3229-527X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105023369","display_name":"Angel E. Maldonado Lopez","orcid":"https://orcid.org/0009-0003-9329-2814","observed_orcids":["https://orcid.org/0009-0003-9329-2814"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angel E. Maldonado L\u00f3pez","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-9329-2814","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061743196","display_name":"Vicky A. Appleman","orcid":"https://orcid.org/0000-0002-9132-1322","observed_orcids":["https://orcid.org/0000-0002-9132-1322"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vicky A. Appleman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9132-1322","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069979641","display_name":"E. Jane Leonard","orcid":"https://orcid.org/0009-0000-6261-2289","observed_orcids":["https://orcid.org/0009-0000-6261-2289"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Jane Leonard","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-6261-2289","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091489500","display_name":"Alexander Parent","orcid":"https://orcid.org/0000-0001-6419-3719","observed_orcids":["https://orcid.org/0000-0001-6419-3719"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander Parent","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6419-3719","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044989932","display_name":"Yu-Chung Huang","orcid":"https://orcid.org/0000-0003-4513-518X","observed_orcids":["https://orcid.org/0000-0003-4513-518X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yu-Chung Huang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4513-518X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064126602","display_name":"Camden Phillip Bay","orcid":"https://orcid.org/0000-0001-7197-3465","observed_orcids":["https://orcid.org/0000-0001-7197-3465"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Camden Bay","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7197-3465","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5121677535","display_name":"Cong Li","orcid":"https://orcid.org/0009-0000-9658-5717","observed_orcids":["https://orcid.org/0009-0000-9658-5717"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cong Li","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-9658-5717","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007877117","display_name":"Neil B. Lineberry","orcid":"https://orcid.org/0000-0001-9156-4423","observed_orcids":["https://orcid.org/0000-0001-9156-4423"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Neil Lineberry","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9156-4423","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5121628118","display_name":"Jeffrey Raizer","orcid":"https://orcid.org/0009-0003-8469-2509","observed_orcids":["https://orcid.org/0009-0003-8469-2509"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey Raizer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-8469-2509","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075832689","display_name":"Daniel J. Olson","orcid":"https://orcid.org/0000-0001-8902-7661","observed_orcids":["https://orcid.org/0000-0001-8902-7661"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel J. Olson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8902-7661","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5055476105","display_name":"Steven J. Chmura","orcid":"https://orcid.org/0000-0001-8851-7108","observed_orcids":["https://orcid.org/0000-0001-8851-7108"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven J. Chmura","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8851-7108","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/hypofractionated-radiotherapy","display_name":"hypofractionated radiotherapy","score":0.996999979019165},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.906000018119812},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6830000281333923},{"id":"https://openalex.org/keywords/preclinical-efficacy","display_name":"preclinical efficacy","score":0.5270000100135803}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8536999821662903},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8364999890327454},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.43050000071525574},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.3882000148296356},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.3682999908924103},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3675000071525574},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.33390000462532043},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3278000056743622},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.3172000050544739},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2533000111579895},{"id":"https://openalex.org/C19527891","wikidata":"https://www.wikidata.org/wiki/Q1120908","display_name":"Medical physics","level":1,"score":0.25270000100135803},{"id":"https://openalex.org/C155806632","wikidata":"https://www.wikidata.org/wiki/Q5299253","display_name":"Dose fractionation","level":3,"score":0.25110000371932983}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2767-9764.30977621","doi":"https://doi.org/10.1158/2767-9764.30977621","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.30977621","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Table_S1_from_Phase_1b_Study_of_Dazostinag_plus_Pembrolizumab_after_Hypofractionated_Radiotherapy_in_Patients_with_Select_Advanced_Solid_Tumors/30977621/1/files/60717029.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2767-9764.30977621","doi":"https://doi.org/10.1158/2767-9764.30977621","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.30977621","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Table_S1_from_Phase_1b_Study_of_Dazostinag_plus_Pembrolizumab_after_Hypofractionated_Radiotherapy_in_Patients_with_Select_Advanced_Solid_Tumors/30977621/1/files/60717029.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7117739596.pdf","grobid_xml":"https://content.openalex.org/works/W7117739596.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7117664284","https://openalex.org/W7117667529","https://openalex.org/W7117765122","https://openalex.org/W7117652544","https://openalex.org/W7117740526","https://openalex.org/W7117698245","https://openalex.org/W4416714719","https://openalex.org/W4402561069","https://openalex.org/W7117698889","https://openalex.org/W4387811279"],"abstract_inverted_index":{"Preclinical":[0],"efficacy":[1],"study":[2],"(groups)":[3]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2025-12-31T00:00:00"}